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Abstract
Background: Reference genome selection is a prerequisite for successful analysis of next generation sequencing
(NGS) data. Current practice employs one of the two most recent human reference genome versions: HG19 or
HG38. To date, the impact of genome version on SNV identification has not been rigorously assessed.
Methods: We conducted analysis comparing the SNVs identified based on HG19 vs HG38, leveraging whole
genome sequencing (WGS) data from the genome-in-a-bottle (GIAB) project. First, SNVs were called using 26
different bioinformatics pipelines with either HG19 or HG38. Next, two tools were used to convert the called SNVs
between HG19 and HG38. Lastly we calculated conversion rates, analyzed discordant rates between SNVs called
with HG19 or HG38, and characterized the discordant SNVs.
Results: The conversion rates from HG38 to HG19 (average 95%) were lower than the conversion rates from HG19
to HG38 (average 99%). The conversion rates varied slightly among the various calling pipelines. Around 1.5% SNVs
were discordantly converted between HG19 or HG38. The conversions from HG38 to HG19 had more SNVs which
failed conversion and more discordant SNVs than the opposite conversion (HG19 to HG38). Most of the discordant
SNVs had low read depth, were low confidence SNVs as defined by GIAB, and/or were predominated by G/C alleles
(52% observed versus 42% expected).
Conclusion: A significant number of SNVs could not be converted between HG19 and HG38. Based on careful
review of our comparisons, we recommend HG38 (the newer version) for NGS SNV analysis. To summarize, our
findings suggest caution when translating identified SNVs between different versions of the human reference
genome.
Keywords: Next generation sequencing, Human reference genomes, SNV, Calling pipeline comparison
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Background
Next generation sequencing (NGS), especially human
whole genome sequencing (WGS), enables precision
medicine and provides a bais for population genetics by
directly querying the genetic architecture of individuals
with single nucleotide resolution [1]. NGS technology em-
powers researchers to extract meaningful genetic informa-
tion from a genome rapidly, which is a driving imperative
for the success of clinical applications [2–5]. For example,
genetic variants associated with human disease risk could
be pinpointed via NGS analysis, accelerating successful
diagnosis or precision treatment identification [6–8].
Single nucleotide variant (SNV) detection and genotype
determination are paramount to the success of genetic
studies [9]. Successful bioinformatic analysis plays a key
role in NGS data interpretation [10–12]. Most bioinformat-
ics approaches rely on alignment [13], a step where short
sequencing reads from a sequencing platform are mapped
to the long string of the reference genome. After the first
version of the human genome was published [14, 15], sub-
sequent incremental improvements on the human genome
have been released thus and today many versions of the hu-
man genome exist. Since different human reference gen-
ome versions currently are in use [16], assessing and
understanding concordance between genetic variants
detected using different reference genomes is important for
successful translation of NGS findings into clinically action-
able discoveries. Historically, the newest release is recom-
mended by the community for its accuracy [17]. However,
to build on previous research results or make a current
study comparable to results obtained using previous human
reference genome versions [18–20], genetic variants ob-
tained from one reference genome version must sometimes
be converted to another older version.
To address this common challenge, several tools have
been developed for converting between different human
genome versions [16]. However, the concordance be-
tween the genetic variants obtained using one version
versus those converted from another version has not
been assessed to date. The human reference genome
hs37d5 (ftp://ftp-trace.ncbi.nlm.nih.gov/1000genomes/
ftp/ technical/reference/phase2_reference_assembly_se-
quence/hs37d5.fa.gz) (termed as HG19 hereafter) and
GRCh38 (ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCA/
000/001/405/ GCA_000001405.15_GRCh38/seqs_for_a-
lignment_pipelines.ucsc_ids/
GCA_000001405.15_GRCh38_no_alt_plus_hs38d1_ana-
lysis_set.fna.gz) (termed as HG38 hereafter) are by far
the two most widely used versions of the human refer-
ence genome in WGS data analysis in 2018. Therefore,
we conducted analysis comparing SNVs identified in
GIAB WGS data [21, 22] using HG19 or HG38 to assess
the consistency between these two versions of human
reference genome. SNVs were called using twenty-six
different pipelines with alignments to HG19 or HG38.
Two conversion tools (Picard [23] (http://broadinstitu-
te.github.io/picard/) and CrossMap [23]) were utilized to
convert between HG19 and HG38. The conversion rate
and discordant rate in SNVs generated using HG19 or
HG38 were calculated. The characteristics of the dis-
cordant SNVs were studied and detailed herein.
Methods
Study design
This study consists of four main phases:
1. Reads were aligned to HG19 or HG38 using three
aligners (Bowtie2, BWA, ISAAC).
2. SNVs were called using three algorithms
(FreeBayes, GATK HaplotypeCaller (HC), ISAAC,
SAMtools).
3. Coordinates of SNVs were converted between
HG19 and HG38 using two tools (Picard,
CrossMap).
4. Comparative analysis was conducted on the
converted SNVs from step 3 (Fig. 1).
First, the raw reads downloaded from GIAB were aligned
to human reference genomes HG19 and HG38 separately
using three popular aligners (BWA-mem [24], Bowtie2 [25]
and ISAAC [26]). For each raw BAM file from each align-
ment, a GATK recalibration BAM file was generated follow-
ing the GATK community recommended guidelines [27, 28].
For each of the four BAM files from each aligner, three call-
ing algorithms (ISAAC [26], HC [28], SAMtools [29] and
FreeBayes [30]) were used to call SNVs. Next, 26 sets of
SNVs (24 generated using above described pipelines and 2
downloaded from GIAB) from HG19 (termed as
38HG19_SNVs hereafter) were converted to SNVs corre-
sponding to HG38 (termed as 19HG38_SNVs hereafter).
Similarly, the 26 sets of SNVs from HG38 (termed as
19HG38_SNVs hereafter) were converted to HG19 (termed
as 38HG19_SNVs hereafter). The SNV conversions between
HG38 and HG19 were performed using LiftoverVcf from the
Picard package (http://broadinstitute.github.io/picard/) (Pic-
ard is used hereafter) and CrossMap [23]. Then, comparisons
between HG19_SNVs and 38HG19_SNVs and between
HG38_SNVs and 19HG38_SNVs based on genome position
and genotype information were conducted with in-house
perl scripts. The discordant SNVs were evaluated for read
depth and annotated as being GIAB low and high confidence
regions. Lastly, the discordant SNVs were partitioned by the
four reference alleles to examine their G/C balance.
Data downloaded
Sequencing data from GIAB
The WGS data from CEPH/HapMap sample NA12878
from the GIAB project [21] was downloaded from ftp://
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ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/NA12878/
NIST_NA12878_HG001_HiSeq_300x/. The raw reads at
~300X were from the Illumina HiSeq 2500 using
paired-end library with 148 base pairs (bp) in read
length.
SNVs from GIAB
SNVs in GIAB’s Novoalign aligned HG19 and HG38
data were called using HC v3.5 [31] and FreeBayes
0.9.20 [30]. These sets of SNVs were downloaded from
GIAB (ftp://ftp-trace.ncbi.nlm.nih.gov/giab/ftp/release/
NA12878_HG001/latest).
Alignment
The raw reads were aligned to HG19 and HG38. Three
aligners were used: BWA (v0.7.15) [24], Bowtie2 (v2.2.9)
[25] and ISAAC (v01.15.04.01) [26]. For BWA, default
parameters were used with a minimum seed length of
19 bp. For Bowtie2, the length of seed substrings was set
at 22 bp with 0 bp mismatch in the seed allowed. For
ISAAC, the seed length was set at 32 bp. The alignment
rate for each aligner was calculated by SAMtools (v2.3.0)
[32] based on the aligner produced BAM files. All align-
ment tasks were run in parallel on the local cluster at
National Center for Toxicological Research.
GATK recalibration
The GATK best practices workflow recommends GATK
post-processing recalibration [28], which is believed to
improve variant calling accuracy. In addition to the
BAM files yielded from alignment, we generated add-
itional BAM files by applying duplicate marking, local
realignment around indels and base quality score recali-
bration for SNV calling. First, duplicates were marked by
the MarkDuplicates and AddOrReplaceReadGroups
commands from Picard tools (v2.7.1, http://broadinstitu-
te.github.io/picard/). Subsequently, local realignment
around known indels was done by the IndelRealigner
command in GATK (v3.7) [28] with known indels from
the 1000 genome project for both HG19 and HG38.
Lastly, the BaseRecalibrator and PrintReads commands
in GATK were run to apply base calibration. Both the
recalibrated BAM files and the original BAM files were
used for SNV calling.
SNV calling
Three different callers (FreeBayes (v1.1.0–1) [30], HC
(v3.7) [28], ISAAC (v1.0.7) [26], SAMtools (v1.3.1) [29])
were run on the BAM files to call SNVs. Option “-X -0
-u -v” was utilized for FreeBayes. For HC, the minimum
phred-scaled confidence threshold at which variants
should be called was set at 30 and reads with wonky
Fig. 1 Study design. Whole genome sequencing data from GIAB reference sample NA12878 was downloaded and aligned to human genomes
HG19 and HG38 using three aligners followed by SNVs calling using various calling algorithms. The SNVs were then converted between the two
reference genomes using Picard and CrossMap. To pinpoint discordant SNVs, converted SNVs were compared against SNVs identified by directly
using the target reference genome version. Finally, discordant SNVs were characterized by read depth, low-confidence frequency and prevalence
of G/C reference alleles
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CIGAR strings were removed by “-rf BadCigar”. For
ISAAC, SNV calling was run with a minimum MAPQ
score equal to 20 and a minimum genotype score less
than 30 as filters. SNVs were called by SAMtools using
the mpileup and bcftools (v1.3.1) [33] commands.
Therefore, we called SNVs using the 20 pipelines listed
in Table 1, using either HG19 or HG38.
VCF file processing
Indels and structural variants such as copy number vari-
ations are not as reproducible as SNVs [34, 35], there-
fore indel and structural variant concordance from
different versions of the human reference genome is not
assessed here. Only SNVs from each call set were kept
for assessment of reference genome version impact.
Vcftools (v0.1.15) [36] was used to remove indels from
the VCF files prior to the comparative analyses.
SNV conversion
Coordinate conversion is needed for SNV comparison
between two different versions of the reference genome.
Two conversion tools were used to convert SNVs be-
tween HG19 and HG38. The first tool is Picard (Lifto-
verVcf command from Picard, v2.7.1, http://
broadinstitute.github.io/picard/). The second tool is a
standalone program named CrossMap [23]. Both tools
are popular and request a fasta file of reference genome
and chain file as common inputs. A chain file is a text
file defined by UCSC which records chromosomal co-
ordinate relationships between different genomes [16].
Conversion rate calculation
The conversion efficiency was assessed using conversion
rates which were calculated for HG19 to HG38 by Pic-
ard and CrossMap using Eqs. (1) and (2), respectively,
and for HG38 to HG19 by Picard and CrossMap using
Eqs. (3) and (4), respectively, for all 40 sets of SNV calls.
CRHG19Picard ¼ 100
19HG38 SNVsPicard
HG19 SNVs
ð1Þ
CRHG19CrossMap ¼ 100
19HG38 SNVsCrossMap
HG19 SNVs
ð2Þ
CRHG38Picard ¼ 100
38HG19 SNVsPicard
HG38 SNVs
ð3Þ
CRHG38CrossMap ¼ 100
38HG19 SNVsCrossMap
HG38 SNVs
ð4Þ
19HG38 SNVsPicard and 19HG38 SNVsCrossMap indicate
SNVs called with HG19 that were successfully converted
to corresponding positions in HG38 using conversion
tools Picard and CrossMap, respectively. 38HG19
SNVsPicard and 38HG19 SNVsCrossMap represent the SNVs
called with HG38 that were successfully converted to
corresponding positions in HG19 using conversion tools
Picard and CrossMap, respectively.
Discordant rate calculation
The converted SNVs which are different from the dir-
ectly called SNVs were identified based on their posi-
tions in the genome only or both their positions and
genotypes. They are named position discordant (PD)
SNVs and genotype discordant (GD) SNVs by the target
reference genome and by the conversion tool, ( PD
SNVsgenometool ) and (GD SNVs
genome
tool ), respectively, for each
set of SNVs. Position discordant rate ( PDRgenometool ) and
genotype discordant rate (GDRgenometool ) are the percentages
of the position discordant SNVs and the genotype dis-
cordant SNVs among the converted SNVs and were cal-
culated using Eqs. (5) to (8) and (9) to (12), respectively.
Table 1 The 26 SNV calling pipelines
Number Aligner GATK recalibration Caller
1 Novoalign N FreeBayes
2 Novoalign N HC
3 ISAAC N FreeBayes
4 ISAAC Y FreeBayes
5 ISAAC N HC
6 ISAAC Y HC
7 ISAAC N ISAAC
8 ISAAC Y ISAAC
9 ISAAC N SAMtools
10 ISAAC Y SAMtools
11 BWA N FreeBayes
12 BWA Y FreeBayes
13 BWA N HC
14 BWA Y HC
15 BWA N ISAAC
16 BWA Y ISAAC
17 BWA N SAMtools
18 BWA Y SAMtools
19 Bowtie2 N FreeBayes
20 Bowtie2 Y FreeBayes
21 Bowtie2 N HC
22 Bowtie2 Y HC
23 Bowtie2 N ISAAC
24 Bowtie2 Y ISAAC
25 Bowtie2 N SAMtools
26 Bowtie2 Y SAMtools
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PDRHG19Picard ¼ 100
PD SNVsHG19Picard
38HG19 SNVsPicard
ð5Þ
PDRHG19CrossMap ¼ 100
PD SNVsHG19CrossMap
38HG19 SNVsCrossMap
ð6Þ
PDRHG38Picard ¼ 100
PD SNVsHG38Picard
19HG38 SNVsPicard
ð7Þ
PDRHG38CrossMap ¼ 100
PD SNVsHG38CrossMap
19HG38 SNVsCrossMap
ð8Þ
GDRHG19Picard ¼ 100
GD SNVsHG19Picard
38HG19 SNVsPicard
ð9Þ
GDRHG19CrossMap ¼ 100
GD SNVsHG19CrossMap
38HG19 SNVsCrossMap
ð10Þ
GDRHG38Picard ¼ 100
GD SNVsHG38Picard
19HG38 SNVsPicard
ð11Þ
GDRHG38CrossMap ¼ 100
GD SNVsHG38CrossMap
19HG38 SNVsCrossMap
ð12Þ
Using the results from BWA alignment and SAMtools
calling as an example, two sets of SNVs were obtained, one
from the alignment onto HG19 (HG19_SNVs) and the other
from the alignment onto HG38 (HG38_SNVs). To convert
HG19_SNVs to the positions in HG38, the HG38 equivalent
SNVs 19HG38 SNVsPicard and 19HG38 SNVsCrossMap were
generated using Picard and CrossMap, respectively. The con-
version rates for HG19_SNVs were then calculated using
Eqs. (1) and (2). In a similar way the conversion rates for
HG38_SNVs were calculated using Eqs. (3) and (4). There-
after, 19HG38 SNVsPicard and 19HG38 SNVsCrossMap were
compared with HG38_SNVs to find the position discordant
SNVs (PD SNVsHG38Picard and PD SNVs
HG38
CrossMap ) and the geno-
type discordant SNVs (GD SNVsHG38Picard and GD SNVs
HG38
CrossMap).
Then the position discordant rates and genotype discordant
rates were calculated using Eqs. (7–8) and Eqs. (11–12), re-
spectively. In an analogous way, the discordant rates for the
converted SNVs from HG38 to HG19 were calculated.
Discordant SNV characterization
To characterize discordant SNVs, we first divided the
position discordant (PD) SNVs and genotype discordant
(GD) SNVs by target genome (TG) version (HG19 or
HG38) and by conversion tool (Picard or CrossMap): PD
SNVsTGtool and GD SNVs
TG
tool . They were further divided
into high-confidence (HC) SNVs (HCPD SNVsTGtool and
HC
GD SNVsTGtool ) and low-confidence (LC) SNVs (
LCPD
SNVsTGtool and
LCGD SNVsTGtool) using the HC/LC SNVs de-
termined by GIAB. In the same way, all SNVs that were
converted to a TG using a conversion tool ( SNVsTGtool )
were divided into HCSNVsTGtool and
LCSNVsTGtool . We then
compared the distributions of HC and LC SNVs by the
logarithmic values of the ratios calculated using eqs. (13)
and (14) for the position discordant SNVs ratio (PR) and
genotype discordant SNVs ratio (GR), respectively.
PR ¼
LCPD SNVsTGtool
LCSNVsTGtool
= HCPD SNVsTGtool
HCSNVsTGtool ð13Þ
GR ¼
LCGD SNVsTGtool
LCSNVsTGtool
= HCGD SNVsTGtool
HCSNVsTGtool ð14Þ
We also compared the percentage of reference allele G
and C between the discordant SNVs for PD SNVsTGtool and
GD SNVsTGtool using an in-house Perl script. All source
data and scripts are provided in the Additional file 1.
Results and discussion
HG19 and HG38 produce substantially different
alignments
The alignment rates of the three aligners run with HG19
and HG38 are listed in Table 2. The reads aligned well
to both HG19 and HG38, indicating high quality se-
quencing data from GIAB and ensuring credibility of the
produced BAM files for subsequent SNV calling.
BWA-mem had the highest alignment rate, and ISAAC
and Bowtie2 were tied at a slightly lower alignment rate.
No significant difference in overall alignment rates be-
tween HG19 and HG38 was observed across the three
aligners.
However, read coverage across reference genome
alignments showed significant differences between
HG19 and HG38. Around 6.5% of the bases in HG19
and 4.4% of the bases in HG38 had no reads aligned by
any of the three aligners (Additional file 2: Table S1).
Not surprisingly, the newer genome version (HG38) had
better genome coverage than the older version (HG19),
suggesting preference for the newer version when under-
going sequence analysis. The three aligners produced
very similar genome coverages. Thus, aligner selection
may be a more minor concern in sequencing data ana-
lysis compared to reference genome selection. We
Table 2 Alignment rates between genome versions and
aligners
HG19 HG38
Aligners Alignment Rate (%) Alignment Rate (%)
Bowtie2 98.559 98.503
BWA 99.629 99.633
ISAAC 99.146 99.034
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further calculated coverage for all bases in all alignment
results and examined the coverage distribution from 1
read to 600 reads (Additional file 2: Table S1).
The coverage from each pipeline is plotted against fre-
quency in a log scale with HG19 as red lines and HG38
as blue lines in Fig. 2. The distribution of coverage for
HG19 and HG38 showed significant differences for all
alignments, as evidenced by t-test p-values less than 0.05
for BWA-mem and Bowtie2 and slightly larger than 0.05
for ISAAC (Additional file 2: Table S2). More interest-
ingly, the differences came from both low and high
coverage distributions. For the bases with coverage close
to the sequencing depth (300X), HG19 and HG38 per-
formed equally well. In other words, for genomic regions
with intermediate amounts of aligned reads, the two ver-
sions of human genome were aligned equally. However,
for genomic regions with very high or very low amounts
of aligned reads, HG19 and HG38 more often produced
different alignments. The regions with too few or too
many mapped reads are typically difficult regions to be
assembled and often assemblies of these areas need im-
provement. Therefore, the alignment results for the two
versions of reference genome might be caused by the
improvements of HG38 in these challenging regions.
Translating SNVs identified from very low or high cover-
age regions between genome versions merits caution.
Comparison of coverage distribution between align-
ments without and with GATK realignment (Additional
file 3: Figure S1) revealed that GATK realignment had
very little impact. The t-test p-values were close to 1
(Additional file 2: Table S2) and Pearson correlation co-
efficients were close to 1 (Additional file 2: Table S3).
The coverage distribution for different aligners was com-
pared in Additional file 3: Figure S2. BWA-mem and
Bowtie2 performed almost identically. In contrast,
ISAAC performed differently from the other two
aligners in low coverage genomic regions. Even though
genomic coverage for different aligners was not
Fig. 2 Distribution of genomic coverage. The coverage from each pipeline is plotted against frequency in a log scale with HG19 as red lines and
HG38 as blue lines. The two sub-figures in each row are a specific aligner depicted by the titles above the sub-figures. The three sub-figures in
the left panel are alignment results without GATK realignment while the right panel contains alignment results with GATK realignment
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significantly different, our comparative analysis of cover-
age distribution revealed that genetic variants detected
in low coverage genomic regions from different aligners
should be carefully inspected.
Calling with HG38 generated more SNVs than calling with
HG19
The sequencing data was aligned to HG19 and HG38
using three alignment tools followed by GATK re-
alignment. The alignment results, with and without
realignment, were used to call SNVs using three algo-
rithms, resulting in 48 sets of SNV calls. We also
downloaded four sets of SNVs from GIAB which were
obtained from HC and FreeBayes with alignments to
HG19 and HG38 using Novoalign. The number of
SNVs is plotted in Fig. 3 for all 52 sets of SNVs. No
significant variation in the numbers of SNVs was
found comparing the three aligners. FreeBayes yielded
slightly more SNVs than HC and SAMtools, which
identified slightly more SNVs than ISAAC. However,
the numbers of SNVs identified from the alignments
to the newer version of the human genome (HG38,
red bars) are significantly larger (by about 5%) than
those detected from the alignments to the older ver-
sion (HG19, blue bars) for otherwise identical pipe-
lines. On average, 3,859,100 SNVs were called from
alignment to HG19 and 4,048,565 SNVs were identi-
fied from alignment to HG38, in agreement with what
has been previously reported [37]. Here, the improved
reference genome (HG38) increased the number of
SNVs identified from identical sequencing data, sug-
gesting that genetic variants missed by using HG19
could be identified using HG38. Therefore, we again
recommend the newer version (HG38) for sequencing
data analysis aimed at variant calling.
Conversion from HG38 to HG19 was more error prone
than HG19 to HG38
The conversion rates of all 52 sets of SNVs for the two
conversion tools are plotted in Fig. 4. The two conver-
sion tools, Picard (circles) and CrossMap (diamonds),
performed nearly identically. Interestingly, the conver-
sion rates from HG19 to HG38 (around 99%) were sig-
nificantly higher than the corresponding conversion
rates from HG38 to HG19 (around 95%). In other
words, the coordinates of the older version (HG19)
could be readily converted to the coordinate system of
the newer version (HG38) while a significant number of
SNVs identified from HG38 could not be successfully
converted to HG19.
We extracted depth information and calculated the
frequency of SNVs at each depth (Additional file 2:
Table S4). For the SNVs identified from alignments
using BWA, no significant variation in SNV depth
was found comparing the three calling algorithms or
the two conversion tools. Not surprisingly, for the
SNVs converted successfully (Fig. 5a and c), the con-
versions from HG38 to HG19 (dotted lines) were
similar with those from HG19 to HG38 (solid lines).
However, the depth distributions for the SNVs that
Fig. 3 SNVs called from different pipelines. Numbers of SNVs (y-axis) is plotted as bar height. The x-axis contains pipeline numbers found in Table
1. The blue bars represent HG19 alignments and the red bars represent HG38 alignments
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Fig. 4 Conversion rates. The conversion rates obtained from Picard are plotted as open circles and the conversion rates yielded from CrossMap
are filled diamonds. Results from converting HG38 to HG19 are in blue and results from converting HG19 to HG38 are in red. The x-axis contains
pipeline numbers found in Table 1. The y-axis depicts the conversion rates
Fig. 5 Depth distribution of the converted and not converted SNVs identified from BWA alignment. The number of SNVs (y-axis) is plotted against depth
(x-axis) for SNVs called using FreeBayes (blue), HC (magenta), ISAAC (red), and SAMtools (cyan). The solid lines are conversion results from HG19 to HG38.
The dotted lines are conversion results from HG38 to HG19. a Successfully converted SNVs using CrossMap. b SNVs which were not successfully converted
using CrossMap. c Successfully converted SNVs using Picard. d SNVs which were not successfully converted using Picard
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were (Fig. 5a and c) or were not (Fig. 5b and d) suc-
cessfully converted between the two genomes were
very different. Strikingly, most of the SNVs that were
unable to be converted had very low sequencing
depth. Our results demonstrated that some genomic
regions, such as repeats, present a challenge for read
alignment and are less consistent between different
versions of the human genome. Similar observations
were obtained for the SNVs identified from alignment
results using Bowtie2 and ISAAC (Additional file 2:
Table S4). The SNVs with or without GATK realign-
ment showed very similar depth distributions (Add-
itional file 2: Table S4).
A significant proportion of successfully converted SNVs
were discordant
The SNVs identified from alignment to a genome
version (“source version” hereafter) and converted to an-
other genome version (“target version” hereafter) are
expected to also be detected from alignment directly to
the target version. However, some of the successfully
converted SNVs were not identified from alignment dir-
ectly to the target version and are termed hereafter as
“discordant SNVs”. The rate of discordant SNVs com-
pared to the total of successfully converted SNVs was
calculated for all 40 sets of SNVs (Fig. 6a). On average,
around 1.5% of successfully converted SNVs were not
Fig. 6 Discordant SNVs. a Rates of discordant SNVs in the successfully converted SNVs are portrayed on the y-axis. b Ratios of position discordant
SNVs to genotype discordant SNVs are depicted on the y-axis. The results from Picard are open circles and the results from CrossMap are filled
diamonds. Conversions from HG38 to HG19 are in blue and conversions from HG19 to HG38 are in red. The x-axis contains pipeline numbers
from Table 1
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detected from any alignments directly to the target
version. Intriguingly, the discordant rates of the SNVs
successfully converted to HG19 (from HG38) were con-
sistently higher than the discordant rates for the SNVs
successfully converted to HG38 (from HG19). The SNVs
identified from alignment to the newer version (HG38)
not only had more SNVs that could not be converted to
the older version HG19 (Fig. 4) but also had a higher
discordant rate for the converted SNVs compared with
the opposite conversion. This result indicates that trans-
lation of findings from the newer version (HG38) to the
older version (HG19) should be done cautiously. In con-
trast to the conversion rates, the discordant rates from
Picard conversions were consistently lower than the
discordant rates from CrossMap conversion across all
calling pipelines. The four sets of SNVs downloaded
from GIAB yielded discordant rates between 1.94 and
2.66% (pipeline 1 and 2 in Fig. 6a), slightly higher than
the discordant rates from the other 36 sets of SNV calls.
For the three alignment tools we used, Bowtie2 demon-
strated the lowest discordant rates (1.10% ± 0.20%);
BWA had the highest discordant rates and highest
variation (1.80% ± 0.41%); ISAAC was in the middle (dis-
cordant rates 1.51% ± 0.24%).
We next defined properties of the discordant SNVs.
The discordant SNVs that were not detected from align-
ment directly to the target version are hence named
“position discordant SNVs”. The discordant SNVs that
Fig. 7 Ratios of LC to HC discordant SNVs. a Log2 values of the ratios of position discordant SNVs are on the y-axis. b Log2 values of the ratios of
genotype discordant SNVs on the y-axis. The results from Picard are open circles and the results from CrossMap are filled diamonds. Conversions
from HG38 to HG19 are in blue and conversions from HG19 to HG38 are in red. Numbers along the x-axis come from the pipelines in Table 1
Pan et al. BMC Bioinformatics 2019, 20(Suppl 2):101 Page 26 of 149
were identified from alignment to the target version but
with different genotypes called are hence named “geno-
type discordant SNVs”. We first counted numbers of
position discordant and genotype discordant SNVs. The
ratios of position discordant SNVs to the genotype dis-
cordant SNVs were calculated (Fig. 6b). The log2 values
of the ratios were much larger than 1, indicating that the
majority of the discordant SNVs were position discord-
ant SNVs. Strikingly, CrossMap not only had more dis-
cordant SNVs (Fig. 6a) but also yielded more genotype
discordant SNVs (lower ratios in Fig. 6b) compared with
Picard, which suggests Picard as a superior choice for
conversion between different versions of human gen-
ome. Unlike the discordant rate, the ratios of position
discordant SNVs to genotype discordant SNVs did not
show a significant or consistent difference between the
two genome conversions considered here. No significant
differences were observed between the aligners or the
calling algorithms in this regard.
Discordant SNVs tend to be low confidence calls
To characterize discordant SNVs, we first compared both
the successfully converted SNVs and the discordant SNVs
against the GIAB gold standard set of HC and LC SNVs.
The ratio of position discordant SNVs and genotype dis-
cordant SNV to the converted SNVs were calculated using
eqs. (13) and (14) as described in methods. The log2 values
of the PR (position discordant ratio) and GR (genotype dis-
cordant ratio) for all 40 sets of SNVs are plotted in Fig. 7.
Position discordant SNVs (Fig. 7a) and genotype discordant
SNVs (Fig. 7b) were more often LC as compared to
successfully converted SNVs. Converting from HG38 to
HG19 generated significant higher log2 PR values (average
of 10.85) than the opposite conversion (average of 8.62) for
all 52 sets of SNVs converted using either conversion tool
(Fig. 7a). Thus, LC SNVs are a major source of position dis-
cordant SNVs and present a HG38 to HG19 conversion
challenge. In contrast, no significant differences were found
for the GR values when converting either way between
HG38 and HG19 (Fig. 7b). Taken together, these results
demonstrate that HC and LC SNVs equally contributed to
the genotype discordant SNVs relative to the successfully
converted SNVs for both conversions. Interestingly, the two
conversion tools did not show a significant difference in PR
values (Fig. 7a), although CrossMap had consistently higher
GR values than Picard (Fig. 7b). The PR and GR values var-
ied substantially between aligners and calling algorithms;
but no consistent trend was observed.
Discordant SNVs are G/C rich
G/C content is well-known to impact SNV calling [38, 39].
To investigate the influence of reference alleles G and C on
conversion discordance between HG19 and HG38, we
summarized reference allele base composition for discord-
ant SNVs (Additional file 3: Figures S3-S10). The average
base composition and standard deviation for the discordant
SNVs obtained from conversions of all 52 sets of SNVs was
calculated. The discordant SNVs were characterized by
each of the four individual bases as well as for the total of
G and C together. The nucleotide balance results are listed
in Table 3. Importantly, the discordant SNVs had higher
GC content (52.24 to 53.86%) compared to the human ref-
erence genome GC content rate (42%). This difference be-
tween what is expected based on background frequency
and what is observed indicates that SNVs with a G/C refer-
ence present a more substantial conversion challenge. Our
results are consistent with previous literature findings that
NGS technology has lower SNV-calling performance on
CpG islands [40].
Conclusions
We compared SNVs identified using the two most re-
cent versions of the human genome: HG19 and HG38.
Alarmingly, a significant proportion of SNVs were not
successfully converted (around 5% for SNVs identified
using HG38 and 1% for HG19), suggesting that HG38
Table 3 Base composition of discordant SNVs in percentages (mean ± standard deviation)
Type Base Picard CrossMap
HG38➔HG19 HG19➔HG38 HG38➔HG19 HG19➔HG38
Position discordant SNVs A 23.43 ± 0.78 23.74 ± 0.81 23.32 ± 0.81 23.66 ± 0.80
T 23.86 ± 0.67 24.02 ± 0.86 23.64 ± 0.70 23.89 ± 0.85
G 26.21 ± 0.71 25.92 ± 0.8 26.37 ± 0.75 26.06 ± 0.78
C 26.5 ± 0.81 26.32 ± 0.87 26.62 ± 0.81 26.35 ± 0.89
G + C 52.71 ± 1.44 52.24 ± 1.64 52.99 ± 1.49 52.41 ± 1.64
Genotype discordant SNVs A 23.06 ± 1.61 23.07 ± 1.66 23.49 ± 0.88 23.57 ± 0.91
T 23.11 ± 1.66 23.07 ± 1.75 23.59 ± 0.81 23.67 ± 0.93
G 26.74 ± 1.65 26.84 ± 1.92 26.79 ± 0.81 26.19 ± 1.16
C 27.08 ± 1.47 27.02 ± 1.45 26.13 ± 0.92 26.57 ± 0.67
G + C 53.82 ± 2.93 53.86 ± 3.13 52.92 ± 1.62 52.77 ± 1.73
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(the newer version) has some genomic resolution lacking
in the older version. Among the successfully converted
SNVs, about 1.5% could not be found by alignment dir-
ectly to the target genome version. Discordant SNVs had
lower read depth, were more frequently defined as low
confidence by GIAB, and had higher prevalence of refer-
ence alleles G and C than concordant SNVs. By these
various characteristics, discordant SNVs are deemed to
be lower quality. Furthermore, converting SNVs ob-
tained using the newer version (HG38) to the older ver-
sion (HG19) is more challenging than opposite
conversion. Discordant SNVs could be driven by coord-
inate differences between reference genomes and/or by
the conversion tools. Our findings suggest caution when
translating genetic findings between different versions of
the human reference genome. After carefully reviewing
the results of our in depth comparison, we recommend
that newer version (HG38) should be used going for-
ward in SNV analysis.
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